LOINC_NUM
stringlengths 3
8
| COMPONENT
stringlengths 2
246
| PROPERTY
stringlengths 1
29
| TIME_ASPCT
stringlengths 1
15
| SYSTEM
stringlengths 1
106
| SCALE_TYP
stringclasses 10
values | METHOD_TYP
stringlengths 1
57
⌀ | CLASS
stringlengths 2
24
| CLASSTYPE
int64 1
4
| LONG_COMMON_NAME
stringlengths 3
254
| SHORTNAME
stringlengths 2
51
⌀ | EXTERNAL_COPYRIGHT_NOTICE
stringlengths 39
2.6k
⌀ | STATUS
stringclasses 4
values | VersionFirstReleased
stringlengths 1
7
| VersionLastChanged
stringlengths 1
5
|
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
99269-3
|
Clonazolam
|
MCnc
|
Pt
|
Urine
|
Qn
|
Confirm
|
DRUG/TOX
| 1 |
Clonazolam [Mass/volume] in Urine by Confirmatory method
|
Clonazolam Ur Cfm-mCnc
| null |
ACTIVE
|
2.72
|
2.72
|
99270-1
|
8-Aminoclonazolam
|
MCnc
|
Pt
|
Urine
|
Qn
|
Confirm
|
DRUG/TOX
| 1 |
8-Aminoclonazolam [Mass/volume] in Urine by Confirmatory method
|
8-Aminoclonazolam Ur Cfm-mCnc
| null |
ACTIVE
|
2.72
|
2.72
|
99271-9
|
Flualprazolam
|
MCnc
|
Pt
|
Urine
|
Qn
|
Confirm
|
DRUG/TOX
| 1 |
Flualprazolam [Mass/volume] in Urine by Confirmatory method
|
Flualprazolam Ur Cfm-mCnc
| null |
ACTIVE
|
2.72
|
2.72
|
99272-7
|
Alpha-hydroxy flualprazolam
|
MCnc
|
Pt
|
Urine
|
Qn
|
Confirm
|
DRUG/TOX
| 1 |
Alpha-hydroxy flualprazolam [Mass/volume] in Urine by Confirmatory method
|
A-OH flualprazolam Ur Cfm-mCnc
| null |
ACTIVE
|
2.72
|
2.72
|
99273-5
|
Meclonazepam
|
MCnc
|
Pt
|
Urine
|
Qn
|
Confirm
|
DRUG/TOX
| 1 |
Meclonazepam [Mass/volume] in Urine by Confirmatory method
|
Meclonazepam Ur Cfm-mCnc
| null |
ACTIVE
|
2.72
|
2.72
|
99274-3
|
Flubromazepam
|
MCnc
|
Pt
|
Urine
|
Qn
|
Confirm
|
DRUG/TOX
| 1 |
Flubromazepam [Mass/volume] in Urine by Confirmatory method
|
Flubromazepam Ur Cfm-mCnc
| null |
ACTIVE
|
2.72
|
2.72
|
9927-5
|
Q wave depth.lead AVR
|
Elpot
|
Pt
|
Heart
|
Qn
|
EKG
|
EKG.MEAS
| 2 |
Q wave depth in lead AVR
|
Q wave Dpth L-AVR
| null |
ACTIVE
|
1.0i
|
2.48
|
99275-0
|
Phenazepam
|
MCnc
|
Pt
|
Urine
|
Qn
|
Confirm
|
DRUG/TOX
| 1 |
Phenazepam [Mass/volume] in Urine by Confirmatory method
|
Phenazepam Ur Cfm-mCnc
| null |
ACTIVE
|
2.72
|
2.72
|
99276-8
|
3-Hydroxyphenazepam
|
MCnc
|
Pt
|
Urine
|
Qn
|
Confirm
|
DRUG/TOX
| 1 |
3-Hydroxyphenazepam [Mass/volume] in Urine by Confirmatory method
|
3-OH-phenazepam Ur Cfm-mCnc
| null |
ACTIVE
|
2.72
|
2.72
|
99277-6
|
Pyrazolam
|
MCnc
|
Pt
|
Urine
|
Qn
|
Confirm
|
DRUG/TOX
| 1 |
Pyrazolam [Mass/volume] in Urine by Confirmatory method
|
Pyrazolam Ur Cfm-mCnc
| null |
ACTIVE
|
2.72
|
2.72
|
99278-4
|
Flubromazolam
|
MCnc
|
Pt
|
Urine
|
Qn
|
Confirm
|
DRUG/TOX
| 1 |
Flubromazolam [Mass/volume] in Urine by Confirmatory method
|
Flubromazolam Ur Cfm-mCnc
| null |
ACTIVE
|
2.72
|
2.72
|
99279-2
|
Alpha-hydroxy flubromazolam
|
MCnc
|
Pt
|
Urine
|
Qn
|
Confirm
|
DRUG/TOX
| 1 |
Alpha-hydroxy flubromazolam [Mass/volume] in Urine by Confirmatory method
|
A-OH flubromazolam Ur Cfm-mCnc
| null |
ACTIVE
|
2.72
|
2.72
|
992-8
|
D little o super little a Ab
|
PrThr
|
Pt
|
Ser/Plas^Donor
|
Ord
| null |
BLDBK
| 1 |
Do sup(a) Ab [Presence] in Serum or Plasma from Donor
|
Do sup(a) Ab SerPl Donr Ql
| null |
ACTIVE
|
1.0
|
2.56
|
99280-0
|
Cefiderocol
|
Susc
|
Pt
|
Isolate
|
OrdQn
| null |
ABXBACT
| 1 |
Cefiderocol [Susceptibility]
|
Cefiderocol Susc Islt
| null |
ACTIVE
|
2.72
|
2.72
|
99281-8
|
Lefamulin
|
Susc
|
Pt
|
Isolate
|
OrdQn
| null |
ABXBACT
| 1 |
Lefamulin [Susceptibility]
|
Lefamulin Susc Islt
| null |
ACTIVE
|
2.72
|
2.72
|
99282-6
|
FDA-initiated compliance action drug registration and listing inactivation - animal drug
|
-
|
-
|
^FDA product label
|
Nar
| null |
DOC.REF
| 2 |
FDA product label FDA-initiated compliance action drug registration and listing inactivation - animal drug
|
FDA animal drug+list inactivation
| null |
ACTIVE
|
2.72
|
2.72
|
9928-3
|
Q wave depth.lead I
|
Elpot
|
Pt
|
Heart
|
Qn
|
EKG
|
EKG.MEAS
| 2 |
Q wave depth in lead I
|
Q wave Dpth L-I
| null |
ACTIVE
|
1.0i
|
2.48
|
99283-4
|
Tegner activity scale panel
|
-
|
Pt
|
^Patient
|
-
|
Tegner
|
PANEL.SURVEY.GNHLTH
| 4 |
Tegner Activity Scale panel [Tegner]
| null | null |
ACTIVE
|
2.72
|
2.72
|
99284-2
|
Activity level before injury
|
Find
|
Pt
|
^Patient
|
Nom
| null |
SURVEY.GNHLTH
| 4 |
Activity level before injury
| null | null |
ACTIVE
|
2.72
|
2.72
|
99285-9
|
Current activity level
|
Find
|
Pt
|
^Patient
|
Nom
| null |
SURVEY.GNHLTH
| 4 |
Current activity level
| null | null |
ACTIVE
|
2.72
|
2.72
|
99286-7
|
Provision of current reconciled medication list to subsequent provider at transfer
|
Find
|
Pt
|
^Patient
|
Ord
|
CMS Assessment
|
SURVEY.CMS
| 4 |
Provision of current reconciled medication list to subsequent provider at transfer [CMS Assessment]
| null | null |
ACTIVE
|
2.72
|
2.72
|
99287-5
|
Checklist of nonverbal pain indicators panel
|
-
|
Pt
|
^Patient
|
-
|
CNPI
|
PANEL.SURVEY.CNPI
| 4 |
Checklist of nonverbal pain indicators panel [CNPI]
| null |
Copyright. Karen S. Feldt, PhD, RN, GNP-BC Used with permission
|
ACTIVE
|
2.72
|
2.72
|
99288-3
|
Checklist of nonverbal pain indicators with movement panel
|
-
|
Pt
|
^Patient
|
-
|
CNPI
|
PANEL.SURVEY.CNPI
| 4 |
Checklist of nonverbal pain indicators with movement panel [CNPI]
| null |
Copyright. Karen S. Feldt, PhD, RN, GNP-BC Used with permission
|
ACTIVE
|
2.72
|
2.72
|
99289-1
|
Nonverbal vocal complaints during movement
|
Find
|
Pt
|
^Patient
|
Ord
| null |
SURVEY.CNPI
| 4 |
Nonverbal vocal complaints during movement
| null | null |
ACTIVE
|
2.72
|
2.72
|
99290-9
|
Facial grimaces or winces during movement
|
Find
|
Pt
|
^Patient
|
Ord
| null |
SURVEY.CNPI
| 4 |
Facial grimaces or winces during movement
| null | null |
ACTIVE
|
2.72
|
2.72
|
9929-1
|
Q wave depth.lead II
|
Elpot
|
Pt
|
Heart
|
Qn
|
EKG
|
EKG.MEAS
| 2 |
Q wave depth in lead II
|
Q wave Dpth L-II
| null |
ACTIVE
|
1.0i
|
2.48
|
99291-7
|
Bracing during movement
|
Find
|
Pt
|
^Patient
|
Ord
| null |
SURVEY.CNPI
| 4 |
Bracing during movement
| null | null |
ACTIVE
|
2.72
|
2.72
|
99292-5
|
Rubbing during movement
|
Find
|
Pt
|
^Patient
|
Ord
| null |
SURVEY.CNPI
| 4 |
Rubbing during movement
| null | null |
ACTIVE
|
2.72
|
2.72
|
99293-3
|
Restlessness during movement
|
Find
|
Pt
|
^Patient
|
Ord
| null |
SURVEY.CNPI
| 4 |
Restlessness during movement
| null | null |
ACTIVE
|
2.72
|
2.72
|
99294-1
|
Verbal complaints during movement
|
Find
|
Pt
|
^Patient
|
Ord
| null |
SURVEY.CNPI
| 4 |
Verbal complaints during movement
| null | null |
ACTIVE
|
2.72
|
2.72
|
99295-8
|
With movement score
|
Score
|
Pt
|
^Patient
|
Qn
|
CNPI
|
SURVEY.CNPI
| 4 |
With movement score [CNPI]
| null |
Copyright. Karen S. Feldt, PhD, RN, GNP-BC Used with permission
|
ACTIVE
|
2.72
|
2.72
|
99296-6
|
Checklist of nonverbal pain indicators at rest panel
|
-
|
Pt
|
^Patient
|
-
|
CNPI
|
PANEL.SURVEY.CNPI
| 4 |
Checklist of nonverbal pain indicators at rest panel [CNPI]
| null |
Copyright. Karen S. Feldt, PhD, RN, GNP-BC Used with permission
|
ACTIVE
|
2.72
|
2.72
|
99297-4
|
Nonverbal vocal complaints while at rest
|
Find
|
Pt
|
^Patient
|
Ord
| null |
SURVEY.CNPI
| 4 |
Nonverbal vocal complaints while at rest
| null | null |
ACTIVE
|
2.72
|
2.72
|
99298-2
|
Facial grimaces or winces while at rest
|
Find
|
Pt
|
^Patient
|
Ord
| null |
SURVEY.CNPI
| 4 |
Facial grimaces or winces while at rest
| null | null |
ACTIVE
|
2.72
|
2.72
|
99299-0
|
Bracing while at rest
|
Find
|
Pt
|
^Patient
|
Ord
| null |
SURVEY.CNPI
| 4 |
Bracing while at rest
| null | null |
ACTIVE
|
2.72
|
2.72
|
99300-6
|
Restlessness while at rest
|
Find
|
Pt
|
^Patient
|
Ord
| null |
SURVEY.CNPI
| 4 |
Restlessness while at rest
| null | null |
ACTIVE
|
2.72
|
2.72
|
99301-4
|
Rubbing while at rest
|
Find
|
Pt
|
^Patient
|
Ord
| null |
SURVEY.CNPI
| 4 |
Rubbing while at rest
| null | null |
ACTIVE
|
2.72
|
2.72
|
99302-2
|
Verbal complaints while at rest
|
Find
|
Pt
|
^Patient
|
Ord
| null |
SURVEY.CNPI
| 4 |
Verbal complaints while at rest
| null | null |
ACTIVE
|
2.72
|
2.72
|
99303-0
|
At rest score
|
Score
|
Pt
|
^Patient
|
Qn
|
CNPI
|
SURVEY.CNPI
| 4 |
At rest score [CNPI]
| null |
Copyright. Karen S. Feldt, PhD, RN, GNP-BC Used with permission
|
ACTIVE
|
2.72
|
2.72
|
99304-8
|
Total score
|
Score
|
Pt
|
^Patient
|
Qn
|
CNPI
|
SURVEY.CNPI
| 4 |
Total score [CNPI]
| null |
Copyright. Karen S. Feldt, PhD, RN, GNP-BC Used with permission
|
ACTIVE
|
2.72
|
2.72
|
99305-5
|
Checklist of nonverbal pain indicators assessment
|
Imp
|
Pt
|
^Patient
|
Nom
|
CNPI
|
SURVEY.CNPI
| 4 |
Checklist of nonverbal pain indicators assessment [CNPI]
| null |
Copyright. Karen S. Feldt, PhD, RN, GNP-BC Used with permission
|
ACTIVE
|
2.72
|
2.72
|
99306-3
|
Choriogonadotropin.beta subunit heterophile Ab interference panel
|
-
|
Pt
|
Ser
|
-
| null |
PANEL.CHEM
| 1 |
Choriogonadotropin.beta subunit heterophile Ab interference panel - Serum
|
B-HCG heterph Ab intrf Pnl Ser
| null |
ACTIVE
|
2.72
|
2.72
|
99307-1
|
Choriogonadotropin.beta subunit heterophile Ab interference
|
PrThr
|
Pt
|
Ser
|
Ord
| null |
CHEM
| 1 |
Choriogonadotropin.beta subunit heterophile Ab interference [Presence] in Serum
|
B-HCG heterph Ab intrf Ser Ql
| null |
ACTIVE
|
2.72
|
2.72
|
99308-9
|
Acid alpha glucosidase cross-reactive immunologic material (CRIM)
|
PrThr
|
Pt
|
WBC
|
Ord
|
IB
|
CHEM
| 1 |
Acid alpha glucosidase cross-reactive immunologic material (CRIM) [Presence] in Leukocytes by Immunoblot
|
AAG CRIM WBC Ql IB
| null |
ACTIVE
|
2.72
|
2.72
|
9930-9
|
Q wave depth.lead III
|
Elpot
|
Pt
|
Heart
|
Qn
|
EKG
|
EKG.MEAS
| 2 |
Q wave depth in lead III
|
Q wave Dpth L-III
| null |
ACTIVE
|
1.0i
|
2.48
|
99309-7
|
Acid alpha glucosidase cross-reactive immunologic material (CRIM)
|
PrThr
|
Pt
|
Tissue
|
Ord
|
IB
|
CHEM
| 1 |
Acid alpha glucosidase cross-reactive immunologic material (CRIM) [Presence] in Tissue by Immunoblot
|
AAG CRIM tiss Ql IB
| null |
ACTIVE
|
2.72
|
2.72
|
99310-5
|
Total score^^adjusted for age
|
Score
|
Pt
|
^Patient
|
Qn
| null |
CLIN.RISK
| 2 |
Total score age adjusted
|
Total score age-adj
| null |
ACTIVE
|
2.72
|
2.72
|
99311-3
|
Seizure onset
|
Type
|
Pt
|
^Patient
|
Nom
| null |
H&P.HX
| 2 |
Seizure onset
|
Seizure onset
| null |
ACTIVE
|
2.72
|
2.72
|
99312-1
|
Seizure frequency
|
Find
|
Pt
|
^Patient
|
Ord
| null |
H&P.HX
| 2 |
Seizure frequency
|
Seizure frequency
| null |
ACTIVE
|
2.72
|
2.72
|
99313-9
|
Time since last seizure
|
Find
|
Pt
|
^Patient
|
Ord
| null |
H&P.HX
| 2 |
Time since last seizure
|
Time since last seizure
| null |
ACTIVE
|
2.72
|
2.72
|
99314-7
|
SARS coronavirus 2 RdRp gene mutation detected
|
Prid
|
Pt
|
XXX
|
Nom
|
Molgen
|
MICRO
| 1 |
SARS-CoV-2 (COVID-19) RdRp gene mutation detected [Identifier] in Specimen by Molecular genetics method
|
SARS-CoV-2 RdRp mut Spec
| null |
ACTIVE
|
2.72
|
2.72
|
99315-4
|
OASIS E - Intervention synopsis - DC, TRN
|
-
|
Pt
|
^Patient
|
-
|
CMS Assessment
|
PANEL.SURVEY.CMS
| 4 |
OASIS E - Intervention synopsis - DC, TRN [CMS Assessment]
| null | null |
ACTIVE
|
2.72
|
2.72
|
9931-7
|
Q wave depth.lead V1
|
Elpot
|
Pt
|
Heart
|
Qn
|
EKG
|
EKG.MEAS
| 2 |
Q wave depth in lead V1
|
Q wave Dpth L-V1
| null |
ACTIVE
|
1.0i
|
2.48
|
9932-5
|
Q wave depth.lead V2
|
Elpot
|
Pt
|
Heart
|
Qn
|
EKG
|
EKG.MEAS
| 2 |
Q wave depth in lead V2
|
Q wave Dpth L-V2
| null |
ACTIVE
|
1.0i
|
2.48
|
9933-3
|
Q wave depth.lead V3
|
Elpot
|
Pt
|
Heart
|
Qn
|
EKG
|
EKG.MEAS
| 2 |
Q wave depth in lead V3
|
Q wave Dpth L-V3
| null |
ACTIVE
|
1.0i
|
2.48
|
9934-1
|
Q wave depth.lead V4
|
Elpot
|
Pt
|
Heart
|
Qn
|
EKG
|
EKG.MEAS
| 2 |
Q wave depth in lead V4
|
Q wave Dpth L-V4
| null |
ACTIVE
|
1.0i
|
2.48
|
99342-8
|
Days since symptom started
|
Find
|
Pt
|
^Patient
|
Ord
| null |
SURVEY.COVID
| 4 |
Days since symptom started
| null | null |
ACTIVE
|
2.72
|
2.72
|
99343-6
|
Days since symptom finished
|
Find
|
Pt
|
^Patient
|
Ord
| null |
SURVEY.COVID
| 4 |
Days since symptom finished
| null | null |
ACTIVE
|
2.72
|
2.72
|
99344-4
|
Sought medical attention for symptoms
|
Find
|
RptPeriod
|
^Patient
|
Nom
| null |
SURVEY.GNHLTH
| 4 |
Sought medical attention for symptoms
| null | null |
ACTIVE
|
2.72
|
2.72
|
99345-1
|
Type of medical attention accessed
|
Type
|
RptPeriod
|
^Patient
|
Nom
| null |
SURVEY.GNHLTH
| 4 |
Type of medical attention accessed
| null | null |
ACTIVE
|
2.72
|
2.72
|
99346-9
|
Temperature taken
|
Find
|
RptPeriod
|
^Patient
|
Ord
| null |
H&P.HX
| 2 |
Temperature taken Reporting Period
|
Temperature taken RptPeriod
| null |
ACTIVE
|
2.72
|
2.72
|
99347-7
|
Body temperature.max
|
Temp
|
RptPeriod
|
^Patient
|
Qn
| null |
H&P.HX
| 2 |
Maximum body temperature Reporting Period
|
Body temp.max RptPeriod
| null |
ACTIVE
|
2.72
|
2.72
|
99348-5
|
Close contact with COVID-19 in last 2W
|
Find
|
2W
|
^Patient
|
Nom
| null |
SURVEY.COVID
| 4 |
Close contact with COVID-19 in last 2W
| null | null |
ACTIVE
|
2.72
|
2.72
|
99349-3
|
Has or had COVID-19
|
Hx
|
Pt
|
^Patient
|
Ord
| null |
SURVEY.COVID
| 4 |
Has or had COVID-19
| null | null |
ACTIVE
|
2.72
|
2.72
|
99350-1
|
Date of first infection onset
|
Date
|
Pt
|
^Patient
|
Nom
| null |
SURVEY.COVID
| 4 |
Date of first infection onset
| null | null |
ACTIVE
|
2.72
|
2.72
|
99351-9
|
Informed of being at severe risk from COVID-19 due to an underlying health condition
|
Find
|
Pt
|
^Patient
|
Ord
| null |
SURVEY.COVID
| 4 |
Informed of being at severe risk from COVID-19 due to an underlying health condition
| null | null |
ACTIVE
|
2.72
|
2.72
|
99352-7
|
Has health problems that require activity limits
|
Find
|
Pt
|
^Patient
|
Ord
| null |
SURVEY.GNHLTH
| 4 |
Has health problems that require activity limits
| null | null |
ACTIVE
|
2.72
|
2.72
|
99353-5
|
Has health problems that require staying at home
|
Find
|
Pt
|
^Patient
|
Ord
| null |
H&P.HX
| 2 |
Has health problems that require staying at home
|
Health prob require stay home
| null |
ACTIVE
|
2.72
|
2.72
|
99354-3
|
Mobility device or aid is regularly used
|
Find
|
Pt
|
^Patient
|
Ord
| null |
H&P.HX
| 2 |
Mobility device or aid is regularly used
|
Mobility device reg used
| null |
ACTIVE
|
2.72
|
2.72
|
99355-0
|
Takes routine medication
|
Find
|
Pt
|
^Patient
|
Nom
| null |
H&P.HX
| 2 |
Takes routine medication
|
Takes routine med
| null |
ACTIVE
|
2.72
|
2.72
|
99356-8
|
Influenza virus vaccination received in last 12Mo
|
Find
|
12Mo
|
^Patient
|
Ord
| null |
H&P.HX
| 2 |
Influenza virus vaccination received in last 12 months
|
Flu vacc last 12Mo
| null |
ACTIVE
|
2.72
|
2.72
|
99357-6
|
COVID-19 health questions panel
|
-
|
Pt
|
^Patient
|
-
| null |
PANEL.SURVEY.COVID
| 4 |
COVID-19 health questions panel
| null | null |
ACTIVE
|
2.72
|
2.72
|
9935-8
|
Q wave depth.lead V5
|
Elpot
|
Pt
|
Heart
|
Qn
|
EKG
|
EKG.MEAS
| 2 |
Q wave depth in lead V5
|
Q wave Dpth L-V5
| null |
ACTIVE
|
1.0i
|
2.48
|
99359-2
|
Person who performed clinical measurement
|
Type
|
Pt
|
^Patient
|
Nom
| null |
H&P.HX
| 2 |
Person who performed clinical measurement
|
Clinical measurement by
| null |
ACTIVE
|
2.72
|
2.72
|
993-6
|
D little o super little a Ab
|
PrThr
|
Pt
|
Ser/Plas
|
Ord
| null |
BLDBK
| 1 |
Do sup(a) Ab [Presence] in Serum or Plasma
|
Do sup(a) Ab SerPl Ql
| null |
ACTIVE
|
1.0
|
2.73
|
99360-0
|
Bovine serum albumin Ab.IgG
|
MCnc
|
Pt
|
Ser
|
Qn
| null |
ALLERGY
| 1 |
Bovine serum albumin (BSA) IgG Ab [Mass/volume] in Serum
|
BSA IgG-mCnc
| null |
ACTIVE
|
2.72
|
2.72
|
99361-8
|
Horse hair+Horse dander Ab.IgG
|
MCnc
|
Pt
|
Ser
|
Qn
| null |
ALLERGY
| 1 |
Horse hair+Horse dander IgG Ab [Mass/volume] in Serum
|
Horse Hair+Dander IgG-mCnc
| null |
ACTIVE
|
2.72
|
2.72
|
99362-6
|
Euroglyphus maynei Ab.IgG
|
MCnc
|
Pt
|
Ser
|
Qn
| null |
ALLERGY
| 1 |
Euroglyphus maynei IgG Ab [Mass/volume] in Serum
|
E maynei IgG-mCnc
| null |
ACTIVE
|
2.72
|
2.72
|
99363-4
|
Triticum spelta Ab.IgG
|
MCnc
|
Pt
|
Ser
|
Qn
| null |
ALLERGY
| 1 |
Spelt IgG Ab [Mass/volume] in Serum
|
Spelt IgG-mCnc
| null |
ACTIVE
|
2.72
|
2.72
|
99364-2
|
Ovalbumin Ab.IgG
|
MCnc
|
Pt
|
Ser
|
Qn
| null |
ALLERGY
| 1 |
Ovalbumin IgG Ab [Mass/volume] in Serum
|
Ovalb IgG-mCnc
| null |
ACTIVE
|
2.72
|
2.72
|
99365-9
|
Sheep milk Ab.IgG
|
MCnc
|
Pt
|
Ser
|
Qn
| null |
ALLERGY
| 1 |
Sheep milk IgG Ab [Mass/volume] in Serum
|
Sheep Milk IgG-mCnc
| null |
ACTIVE
|
2.72
|
2.72
|
9936-6
|
Q wave depth.lead V6
|
Elpot
|
Pt
|
Heart
|
Qn
|
EKG
|
EKG.MEAS
| 2 |
Q wave depth in lead V6
|
Q wave Dpth L-V6
| null |
ACTIVE
|
1.0i
|
2.48
|
99366-7
|
Chicken meat Ab.IgG
|
MCnc
|
Pt
|
Ser
|
Qn
| null |
ALLERGY
| 1 |
Chicken meat IgG Ab [Mass/volume] in Serum
|
Chicken Meat IgG-mCnc
| null |
ACTIVE
|
2.72
|
2.72
|
99367-5
|
Theobroma cacao Ab.IgG
|
MCnc
|
Pt
|
Ser
|
Qn
| null |
ALLERGY
| 1 |
Cocoa IgG Ab [Mass/volume] in Serum
|
Cocoa IgG-mCnc
| null |
ACTIVE
|
2.72
|
2.72
|
99368-3
|
Gliadin Ab.IgG
|
MCnc
|
Pt
|
Ser
|
Qn
| null |
SERO
| 1 |
Gliadin IgG Ab [Mass/volume] in Serum
|
Gliadin IgG Ser-mCnc
| null |
ACTIVE
|
2.72
|
2.72
|
99369-1
|
Dactylis glomerata Ab.IgG
|
MCnc
|
Pt
|
Ser
|
Qn
| null |
ALLERGY
| 1 |
Cocksfoot IgG Ab [Mass/volume] in Serum
|
Cocksfoot IgG-mCnc
| null |
ACTIVE
|
2.72
|
2.72
|
99370-9
|
Tabanus spp Ab.IgG
|
MCnc
|
Pt
|
Ser
|
Qn
| null |
ALLERGY
| 1 |
Horse Fly IgG Ab [Mass/volume] in Serum
|
Horse Fly IgG-mCnc
| null |
ACTIVE
|
2.72
|
2.72
|
99371-7
|
Culex pipiens Ab.IgG
|
MCnc
|
Pt
|
Ser
|
Qn
| null |
ALLERGY
| 1 |
Culex mosquito IgG Ab [Mass/volume] in Serum
|
Culex mosquito IgG-mCnc
| null |
ACTIVE
|
2.72
|
2.72
|
99372-5
|
Platanus acerifolia Ab.IgG
|
MCnc
|
Pt
|
Ser
|
Qn
| null |
ALLERGY
| 1 |
London Plane IgG Ab [Mass/volume] in Serum
|
London Plane IgG-mCnc
| null |
ACTIVE
|
2.72
|
2.72
|
99373-3
|
Alnus incana Ab.IgG
|
MCnc
|
Pt
|
Ser
|
Qn
| null |
ALLERGY
| 1 |
Grey Alder IgG Ab [Mass/volume] in Serum
|
Grey Alder IgG-mCnc
| null |
ACTIVE
|
2.72
|
2.72
|
9937-4
|
Q wave duration.lead AVF
|
Time
|
Pt
|
Heart
|
Qn
|
EKG
|
EKG.MEAS
| 2 |
Q wave duration in lead AVF
|
Q wave dur L-AVF
| null |
ACTIVE
|
1.0i
|
2.48
|
99374-1
|
Betula verrucosa Ab.IgG
|
MCnc
|
Pt
|
Ser
|
Qn
| null |
ALLERGY
| 1 |
Silver Birch IgG Ab [Mass/volume] in Serum
|
Silver Birch IgG-mCnc
| null |
ACTIVE
|
2.72
|
2.72
|
99375-8
|
Corylus avellana pollen Ab.IgG
|
MCnc
|
Pt
|
Ser
|
Qn
| null |
ALLERGY
| 1 |
Hazelnut Pollen IgG Ab [Mass/volume] in Serum
|
Hazelnut Poln IgG-mCnc
| null |
ACTIVE
|
2.72
|
2.72
|
99376-6
|
Olea europaea pollen Ab.IgG
|
MCnc
|
Pt
|
Ser
|
Qn
| null |
ALLERGY
| 1 |
Olive Pollen IgG Ab [Mass/volume] in Serum
|
Olive Poln IgG-mCnc
| null |
ACTIVE
|
2.72
|
2.72
|
99377-4
|
Parietaria judaica Ab.IgG
|
MCnc
|
Pt
|
Ser
|
Qn
| null |
ALLERGY
| 1 |
Pellitory (Parietaria judaica) IgG Ab [Mass/volume] in Serum
|
Pellitory (judaic) IgG-mCnc
| null |
ACTIVE
|
2.72
|
2.72
|
99378-2
|
Vasopressin
|
SCnc
|
Pt
|
Urine
|
Qn
| null |
CHEM
| 1 |
Vasopressin [Moles/volume] in Urine
|
Vasopressin Ur-sCnc
| null |
ACTIVE
|
2.72
|
2.72
|
99379-0
|
Mercury
|
SCnc
|
Pt
|
Milk
|
Qn
| null |
DRUG/TOX
| 1 |
Mercury [Moles/volume] in Milk
|
Mercury Mlk-sCnc
| null |
ACTIVE
|
2.72
|
2.72
|
99380-8
|
Mercury
|
SCnc
|
Pt
|
CSF
|
Qn
| null |
DRUG/TOX
| 1 |
Mercury [Moles/volume] in Cerebral spinal fluid
|
Mercury CSF-sCnc
| null |
ACTIVE
|
2.72
|
2.72
|
99381-6
|
Mercury
|
SCnc
|
Pt
|
Dial fld
|
Qn
| null |
DRUG/TOX
| 1 |
Mercury [Moles/volume] in Dialysis fluid
|
Mercury Dial fld-sCnc
| null |
ACTIVE
|
2.72
|
2.72
|
9938-2
|
Q wave duration.lead AVL
|
Time
|
Pt
|
Heart
|
Qn
|
EKG
|
EKG.MEAS
| 2 |
Q wave duration in lead AVL
|
Q wave dur L-AVL
| null |
ACTIVE
|
1.0i
|
2.48
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.